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Abstract  
Despite its characteristically low sensitivity, sputum smear microscopy remains the standard for diagnosing tuberculosis (TB) in resource-poor 
countries. In an attempt to develop an alternative or adjunct to microscopy, researchers have recently examined the ability of pouched rats to 
detect TB-positive human sputum samples and the microbiological variables that affect their detection. Ten published studies, reviewed herein, 
suggest that the rats are able to detect the specific odor of Mycobacterium tuberculosis, which causes TB, and can substantially increase new-case 
detections when used for second-line TB screening following microscopy. Further research is needed to ascertain the rats' ability to detect TB in 
children and in HIV-positive patients, to detect TB when used for first-line screening, and to be useful in broad-scale applications where cost-
effectiveness is a major consideration. 
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Tuberculosis is an infectious disease caused by Mycobacterium 
tuberculosis. About one-third of Earth's population has latent TB, 
which means that they have been exposed to M. tuberculosis but 
not become ill. About 10% of people with latent TB develop active 
TB, that is, they become ill with the disease, which in 2011 affected 
approximately 8.7 million people and killed 1.4 million of them [1]. 
Most deaths due to TB occur in resource-poor countries located in 
the tropics. Although TB is a treatable and curable disease, it causes 
immense suffering and many deaths in Africa, due in part to the 
absence of a cheap and reliable technique for detecting it. Sputum 
smear microscopy is the standard technique for diagnosing TB in 
resource-poor countries, due to its relatively low cost [2]. In this 
technique, sputum smears are stained with the Ziehl-Neelsen 
method, which causes M. tuberculosis bacteria to appear as bright 
red rods when viewed under a light microscope. Unfortunately, this 
technique misses many cases of TB. Although the technique's 
specificity (ability to detect the absence of active TB) is typically 
above 90%, which is good, the sensitivity of the method (ability to 
detect the presence of active TB) varies widely, ranging from about 
20-80%, and is often poor [3]. In addition to suffering the 
consequences of untreated disease, each patient missed by 
microscopy (or any other diagnostic), and thus not treated, is likely 
to spread the disease to between 10 and 15 other people each year 
[1].  
  
Alternatives to Ziehl-Neelsen microscopy, including fluorescent 
microscopy [3] and the GeneXpert assay [4], have been developed 
and are being adopted, but presently are not widely available in 
resource-poor areas [5]. A decade ago, Bart Weetjens, the founder 
of Anti-Persoonsmijnen Ontmijnende Product Ontwikkeling (APOPO; 
in English, Anti-Personnel Landmines Detection Product 
Development), was aware of the need to develop a viable 
alternative to or adjunct for microscopy for use in resource-poor 
areas. APOPO is a Belgian nongovernmental organization (NGO) 
headquartered in Morogoro, Tanzania that is widely recognized for 
its use of giant African pouched rats (Cricetomys gambianus) to 
detect landmines (e.g. [ 6, 7]). Weetjens knew of historical reports 
by physicians indicating that the breath and sputum of patients with 
consumption (as TB was once termed) often had a tarry odor, and 
he reasoned that this odor could be easily detected by pouched 
rats, which have a much better sense of smell than humans. 
Weetjens also hypothesized that laboratory procedures proven 
successful in teaching pouched rats to detect the odor of 2,4,6-
trinitrotoluene (TNT), the primary explosive in most landmines, 
could be readily adapted to teach them to distinguish TB-positive 
from TB-negative samples, and he and his colleagues set out to 
explore the possibility of using pouched rats to detect human TB by 
sniffing human sputum. The purpose of this article is to review their 





Evidence that Pouched Rats can Detect TB  
  
Pouched rats are large (25-45 cm body length, 1-2 kg body weight) 
burrowing rodents native to sub-Saharan Africa. Details of how the 
rats are maintained at APOPO are provided elsewhere [8]. In the 
first published report of their ability to detect active TB, Weetjens et 
al. [9] described a procedure in which the rats were trained in a 
rectilinear cage to sniff each of 10 holes located along the centerline 
of the cage's floor. A small pot containing a sputum sample taken 
from a patient at a Direct Observation of Treatment Short Course 
(DOTS) TB center in Dar es Salaam, Tanzania was placed 
immediately below each hole. In Tanzania, Zeehl-Nielson 
microscopy is the usual TB diagnostic at DOTS centers, although 
fluorescent microscopy and other techniques are occasionally 
employed. Weetjens et al. arranged for DOTS-center technicians to 
evaluate each sample via microscopy and freeze the remaining 
material, which was transported to APOPO's lab for analysis by the 
rats. In this and other studies, each patient typically provided two 
sputum samples, which is standard practice at the DOTS centers. 
Prior to use in training, each sputum sample was thawed and 
heated to inactivate M. tuberculosis and other infectious micro-
organisms. The rats were trained by operant conditioning to pause 
for at least 5 seconds at holes where the sputum sample was 
positive for TB (as confirmed by microscopy) but not to pause at 
holes where the sputum sample was TB-negative. In essence, the 
training procedure involved differential reinforcement, arranged so 
that rats (which were mildly food deprived) received food only when 
they paused for the required time (5 s) at holes above TB-positive 
samples. When the discrimination was being established, the 
trainers were aware of which samples were TB-positive and TB-
negative, so that they could arrange reinforcement (rewards) 
appropriately. In testing the system, however, trainers did not know 
the status of several samples (termed "unknown", and rats' 
performance on unknown samples was used to index their 
sensitivity and specificity in detecting TB.  
  
In the Weetjens et al. [9] study, two rats were tested with unknown 
samples that were confirmed as TB-positive (67 samples) or TB-
negative (750 samples) by culturing, which is the "gold standard" 
for TB detection. The sensitivity of each individual rat was 73.1%. 
That is, each rat identified as TB-positive 49 of the 67 sputum 
samples identified as TB-positive by culturing. The specificity of one 
rat was 93% and that of the other rat was 93.8%. That is, the first 
rat identified as TB-negative 698 of the 750 sputum samples 
identified as TB-negative by culturing and the second rat identified 
703 of these samples as TB-negative. Weetjens et al. [9] also 
compared rats' evaluation of sputum samples to evaluations made 
by trained DOTS-center microscopists. Summary results were 
presented for 16 rats that evaluated 2,597 sputum samples, of 
which 345 were smear-positive. The mean sensitivity of these rats 
was 87.9% and the mean specificity was 93.3%. More detailed 




Current status of knowledge 
 
These findings were sufficiently promising that the Tanzanian 
Ministry of Health allowed the rats to be used for simulated second-
line screening of sputum samples provided by DOTS-center patients. 
In a study by Weetjens et al. [10], samples from 15,041 patients 
were evaluated by microscopy at the DOTS centers and by the rats. 
The DOTS centers found TB in 1,838 of the patients (12.2%), 
whereas the rats detected the disease in 2,415 patients (16.1%). 
The cases detected by rats but missed by DOTS centers (n = 577) 
increased TB detection by 31.4%, which is statistically, and more 
importantly clinically, significant. In this study, a second microscopy 
was used to confirm the status of samples indicated by the rats as 
TB-positive. The results of screening sputum samples from 
additional DOTS-center patients were analyzed by Poling et al. [11], 
who reported that in 2009 23,101 sputum samples from 10,523 
patients were evaluated, first by DOTS-microscopists and then by 
the rats. DOTS centers identified 2,487 TB-positive sputum samples 
and 1,335 TB-positive patients. The rats indicated 2,085 new 
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samples and 898 new patients at TB-positive. Of these, 927 samples 
and 620 patients were confirmed by APOPO microscopy to be 
positive for TB. Thus, the rats increased the new case detection rate 
by 44%. Poling et al. also reported individual sample-wise data for 
10 rats. The average sensitivity was 86% (range 82-89%) and the 
average specificity was 93% (range 91-95%). As in other studies, 
Poling et al. notified the appropriate DOTS center whenever a 
DOTS-negative patient was deemed TB-positive by APOPO, and the 
DOTS center arranged appropriate activities regarding that patient 
(i.e., contact and treatment). Mahoney et al. [12] reported that in 
2010 Crycetomys evaluated sputum samples from 12,347 patients, 
1,671 (13.5%) of whom were identified as TB-positive by DOTS 
center microscopy. The rats identified an additional 716 patients as 
TB-positive, a 42.7% increase in the TB detection rate. Again, 
individual data were calculated for 10 rats and average sensitivity 
was 72% (range 69-77%) and average specificity was 86% (range 
82-89%). With the exception of two rats that evaluated 67 sputum 
samples confirmed by culturing to be TB-positive and 750 samples 
confirmed to be TB-negative [9], the sensitivity and specificity of 
pouched rats in detecting TB has been confirmed by a second 
microscopy. This is not a strong confirmatory technique and was 
dictated solely by the unavailability of a better alternative. To 
examine the rats' performance relative to the "gold standard" for TB 
detection, Mahoney et al. [13] had rats evaluate 910 sputum 
samples previously evaluated by smear microscopy. All samples 
were also evaluated through culturing and multiplex polymerase 
chain reaction (PCR) was performed on culture growths to classify 
the bacteria. The patient-wise sensitivity of microscopy was 58.0%, 
and the specificity was 97.3%. Used as a group of 10 with a cutoff 
(defined as the number of rat indications to classify a sample as 
positive for M. tuberculosis ) of 1, the rats increased new case 
detection by 46.8% relative to microscopy alone. The average 
sensitivity of the individual rats was 68.4% (range 61.1-73.8%), and 
the mean specificity was 87.3% (range 84.7-90.3%). These results, 
coupled with those of prior studies using a less robust confirmatory 
technique, suggest that pouched rats are a valuable adjunct to, and 
may be a viable substitute for, sputum smear microscopy as a TB 
diagnostic in resource-poor countries. To date, the rats have 
detected over 3,000 cases of TB missed by microscopy.  
  
Improving operational effectiveness and efficiency  
  
Pouched rats can evaluate sputum samples very quickly, but 
considerable time is required to prepare samples for evaluation by 
the rats. Recent studies have evaluated possible strategies for 
reducing the time required to process samples. In one study, 
Mahoney et al. [14] explored whether pouched rats could accurately 
detect active TB by sniffing fixed microscope slides. Because such 
slides are prepared for each sample at DOTS centers and would 
require no further processing before being presented to the rats, 
their use would substantially speed sample evaluation by the rats. 
In the Mahoney et al. [14] study, six trained pouched rats evaluated 
35 DOTS-positive sputum and 315 DOTS-negative sputum samples 
and six other rats evaluated fully prepared smears (slides) from 
those same samples. All of the DOTS-positive samples contained 
high concentrations of M. tuberculosis, which was intended to make 
them easy for the rats to detect. Because the rats can evaluate 
samples quickly, in operational use it is possible to have each 
sample evaluated by more than one animal. When this is done, a 
decision must be made with respect to the proportion of animals 
identifying a sample as TB-positive for the sample to be so 
considered. That is, a specific decision criterion must be determined. 
Mahoney et al. reported sensitivity and specificity data using all 
possible decision criteria (i.e., 1, 2, 3, 4, 5, and 6 of 6 positive). In 
this study, accuracy in evaluating fully prepared smears (microscope 
slides) was highest at a cutoff of 4 of 6 positive indications. With 
this criterion, when samples were presented as microscope slides, 
sensitivity was 70.5% and specificity was 81.7%. The optimal cutoff 
in the sputum condition was 3, which yielded a sensitivity of 94.4% 
and a specificity of 94.4%. These results suggest that the rats can 
detect TB in prepared slides, but that their accuracy in doing so is 
substantially lower than their accuracy in detecting TB in sputum. 
Although further research investigating TB detection from fixed 
slides is warranted, in order to maximize new case detection APOPO 
presently evaluates only sputum presented in pots. Early-on in the 
process of developing the TB diagnostic, a decision was made to 
add 5 ml of phosphate-buffered saline solution (PBS) to each 
sputum sample prior to evaluation by the rats. The rationale for 
doing this was that adding the liquid should increase the volatiles 
available for detection by the rats. No confirmatory data were 
collected, however. A time analysis conducted across two 
consecutive sample-processing days indicated that the use of PBS 
added 70.2 minutes to the time required to process 600 samples 
[15], which is warranted only if addition of the solution improves 
the rats' performance. To determine whether it does so, Mahoney et 
al. (15, Experiment 1) arranged a study in which 10 trained rats 
evaluated an equal number of sputum samples with and without 
PBS added. A within-subjects experimental design was used and the 
results revealed that there was no substantial difference in the 
sensitivity or specificity of individual rats, or of the 10 rats as a 
group, in evaluating samples with or without added PBS. The mean 
sensitivity of the rats was the same, 75.6%, when PBS was and was 
not added to samples. The mean specificity was 77.9% when PBS 
was added and 80.1% when PBS was not added. In view of these 
results, APOPO personnel no longer add PBS to samples.  
  
By convention, microscopists count the number of bacteria they 
observe and categorize TB-positive samples according to bacterial 
load, from AFB (a few bacteria), through the progressively 
increasing categories of +1, +2, and +3 [16]. It is much harder for 
microscopists to detect low concentrations of M. tuberculosis than to 
detect high concentrations, and APOPO receives relatively few AFB 
and +1 samples. Training the rats with a preponderance of high-
concentration samples may well reduce their accuracy in detecting 
low-concentration samples, and artificially inflating the number of 
low-concentration training samples they receive may improve their 
accuracy. Mahoney et al. (15, Experiment 2) evaluated this 
possibility by training five rats with samples as they were received 
from DOTS centers with no regards to bacteria load. They trained 
five other rats only with AFB and +1 samples. When all rats were 
subsequently tested with +1 samples, the mean sensitivity of the 
rats trained with all samples was 55% and the mean sensitivity of 
the rats trained with AFB and +1 samples was 82.8%. The 
difference in mean sensitivity was statistically significant. Mean 
specificities for these respective groups were 85.6% and 82.5; the 
difference in means was not statistically significant. These findings 
suggest that training on low concentration samples improves rats' 
detection of such samples. Unfortunately, insufficient low-
concentration sputum samples are available to make practical use of 
these findings.  
  
Microbiological variables that affect detection  
  
Sputum from patients at DOTS centers contains microorganisms 
other than M. tuberculosis , some virulent, and it is possible that the 
presence of these microorganisms affects the rats' performance. For 
example, Mycobacteria other than M. tuberculosis (non- Mtb 
species, such as M. bovis, M. avium ) might be present and produce 
odors similar to those produced by M. tuberculosis . Further, 
nonmycobacterial species found in the respiratory tract may 
produce an odor similar to that of M. tuberculosis . If so, the rats 
would err by identifying microorganisms other than M. tuberculosis 
as TB-positive. Mgode and his colleagues investigated this issue in a 
series of experiments [17-19] designed to determine whether the 
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rats falsely identify nonmycobacterial species and falsely identify 
non- Mtb mycobacterial species as M. tuberculosis , and which 
compounds within the M. tuberculosis species play an important role 
in detection by rats. In the first experiment in the series [17] 
sputum samples from 289 subjects were analyzed by smear 
microscopy, culture, PCR, and the rats. A group of 10 rats evaluated 
514 processed sputum samples. The sputum samples were 
evaluated for the presence of M. tuberculosis , non-tuberculous 
mycobacteria (Mycobacterium species other than M. tuberculosis ) 
(NTM), and six other microorganisms of the respiratory tract 
(Nocardia spp., Rhodococcus spp., Streptomyces spp., Moraxella 
spp, Candida spp., and Streptococcus pneumonia ). All samples 
evaluated for the presence of Mycobacteria (n=380) were cultured 
on Lowenstein Jensen media to isolate mycobacterial species and 
subjected to multiplex real-time PCR. Conventional multiplex PCR 
was additionally conducted. Nonmycobacterial respiratory tract 
microbes were also cultured from 394 sputum samples and isolates 
were identified by colony and cell morphology and biochemical 
tests. Those samples found negative for Mtb by smear microscopy 
and culture but found positive by the rats underwent gas 
chromatography/mass spectrometry (GC/MS) to identify volatile 
compounds of the microorganisms. Test results yielded 19 smear 
microscopy-positive sputum cases, 37 culture-positive cases, and 5 
TB-suspect cases. The rats identified 45 of the 56 confirmed TB 
cases. The rats also identified 63 of the 228 TB-negative patients as 
TB-positive. Thus, at a cutoff of two rat agreements, patient-wise 
sensitivity was 80.4% while patient-wise specificity was 72.4%. 
About 40% of NTM, M. avium subsp., hominissuis , and M. 
intracellulare samples were detected by the rats, which is 
significantly lower than the detection rate on Mtb (p= .054, Fisher's 
exact test) but also lower than the rats' detection accuracy on some 
nonmycobacterial species. Three nonmycobacterial species were 
identified that produced relatively high detection rates: Rhodoccocus 
(2 out of 3 samples), Nocardia (2 out of 3 samples), and 
Streptomyces (4 out of 10 samples). There were too few samples 
available in these categories to reach a conclusion regarding the 
rats' detection accuracy on these samples and the odor analysis 
failed to identify Mtb markers common to these other 
microorganisms. Rat false alarm rates in smear-negative sputum 
containing other nonmycobacterial species ranged from 0-33.3%. In 
total, the rats indicated 28 of 111 smear-negative samples (25.2%) 
containing one or more of the tested respiratory tract microbes to 
be TB-positive.  
  
In summary, the rats' detection accuracy on samples containing Mtb 
was significantly higher (p < .05) than accuracy on other 
nonmycobacterial species except Rhodococcus spp., Nocardia spp., 
and Streptomyces spp. (p > .05), but the odor analysis results 
indicated that these species do not produce candidate odor markers 
produced by Mtb . It is possible that sputa found negative by smear 
microscopy and culture is in fact positive for TB but below the 
detection thresholds of these tests. It is also possible that the rats' 
detection of these sputum samples is based upon odors 
unassociated with these microorganisms but instead are associated 
with necrotic materials or other byproducts found in the respiratory 
tract produced in response to illness. This possibility is reasonable 
given that all sputum samples were collected from TB clinics and 
thus all patients exhibited symptoms of a respiratory illness. It could 
potentially be evaluating by determining the rats' evaluation of 
sputa from non-symptomatic people. In the second study of the 
series [18], diagnostic performance of the rats on pure cultures 
mixed into negative sputum was compared with performance on 
naturally TB-infected sputum. Pure cultures of Mtb, NTM, clinical 
Mtb isolates, Nocardia spp., Rhodococcus sp., Streptomyces spp., 
Bacillus sp., Candida sp., and Saccharomyces sp. were tested. 
Freeze-dried bacterial strains were reconstituted and inoculated into 
14-20 ml of Middlebrook liquid medium, checked for purity, and 
incubated. All test organisms were heat inactivated in a 90° C water 
bath for 30 min and stored at -20°C until used. Negative sputum 
samples, collected from TB clinics, were confirmed negative by 
smear microscopy (ZN and FM), mycobacterial culture, and the rats. 
These samples were exposed to the same inactivation and storage 
procedures as the test microorganisms. Negative samples were 
spiked with the culture isolates and presented to the rats across a 
period of 94 days. Further, 36 cultures were presented at various 
growth stages. Different volatiles may be associated with the 
various phases and this test provided information regarding the 
most detectable phase of growth. Each session, six rats evaluated 
samples containing 9 test microorganisms, 7 TB-positive controls 
used as reinforcement samples for the rats (these samples were 
mixed with a sterile medium), and 54 negative controls (also mixed 
with a sterile medium). Unlike the prior study, this study found that 
the rats did not detect mycobacterial-related Nocardia spp., 
Rhodococcus sp., or other microbes. The rats discriminated Mtb 
from other microbes (p <.008) and sensitivity on naturally TB-
positive sputum was higher than sensitivity on sputum spiked with 
Mtb cultures (50%). The analysis of rat accuracy on various stages 
of culture indicated that the stage of growth affects performance. 
Very young cultures (≤ 10 days) or old cultures (≥ 41 days) yielded 
much lower sensitivity than cultures taken between 21 and 30 days 
of growth; overall sensitivity was 50% while sensitivity on 11-30-
day cultures was 83.3%. Specificity was 94.4% on negative control 
samples. This study indicated that the rats perform better on 
naturally-infected TB positive sputum and that different stages of 
culture growth yield different levels of sensitivity. That the rats 
perform better on naturally-infected TB- positive sputum suggests 
that background odors differed in these samples and implies that 
characteristics of the host body may affect the rats' performance. 
Therefore, evaluation of the performance of rats in several different 
populations, such as patients at DOTS centers in dissimilar cities and 
inmates in rural prisons, would be useful to determine whether 
detection accuracy varies due to background odors. The results of 
these two studies provided information regarding the mycobacterial 
species and other microorganisms that the rats detect in addition to 
Mtb. In a third study [19], specific odor compounds characteristic of 
Mtb were tested. The purpose of the study was to determine the 
volatile compounds of Mtb-positive sputum detected by the rats and 
whether other microorganisms related to TB, which also cause 
pulmonary disease, are detected by the rats on the basis of these 
odor compounds. The microorganisms studied were non-Mtb, 
Nocardia spp., Streptomyces spp., clinical isolates,Rhodococcus sp., 
Staphylococcus sp., and Candida sp. To identify volatile compounds, 
headspace samples from the microorganisms in various media and 
growth-phases were collected via a closed-loop apparatus fitted with 
an activated charcoal filter for 18-24 h. Compounds recovered from 
at least two cultures, but absent from the blank media, were 
considered significant. Thirteen volatile compounds specific to Mtb 
and 13 shared with other microorganisms were found. Eight 
volatiles unique to Mtb and seven volatiles shared between Mtb, 
non-Mtb mycobacteria, and other microorganisms were presented to 
the rats. The compounds were presented first individually to the rats 
and later in pairs and blends.  
  
Results indicated that rat detection of TB-negative sputa spiked with 
a blend of 6 Mtb-specific volatile compounds was significantly 
different (p=.001) from detection of TB-negative sputa spiked with 
shared volatile compounds. None of these compounds, when 
presented individually, were identified by the rats as TB-positive at a 
statistically significant level. Further, the blend of the three most 
abundant Mtb-specific compounds (methyl nicotinate, methyl 4-
anisate and 2-phenylanisol) was not detected at a statistically 
significant level. Thus, this study indicates that TB detection by the 
rats involves a relatively complex odor profile that likely becomes 
even more complex when dealing with live human subjects. Further, 
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aligned with other scent-detection research [20, 21], it suggests 
that odors detectable as a blend may not evoke the relevant 





Although scientific interest in using animals to detect disease is 
growing, as evidenced by the recent publication of two reviews 
examining dogs' ability to detect ill health in humans [22, 23], this 
general strategy is relatively new, rarely used, and not generally 
accepted by the medical community. Widespread application of any 
animal-based diagnostic, including the use of Cricetomys to detect 
TB, will depend upon the availability of compelling data showing 
that the diagnostic is acceptably accurate and financially viable. 
Although researchers have made considerable progress in 
evaluating pouched rats as second-line TB detectors, they have not 
yet produced an exportable TB-detection system that has been 
independently verified as useful on a broad scale. Moreover, the 
value of pouched rats as second-line TB screens depends on the 
quality of the first-line screen. Put simply, if microscopy were highly 
accurate, there would be no need for the rats. There is a strong 
international push to develop and make widely available a fast, 
inexpensive, and accurate alternative to smear microscopy and, 
when it arrives, there will be no need for second-line screening of 
any type. In the interim, which is of uncertain and potentially 
lengthy duration, the rats may be of clinical value and further 
examination of how best to use them for second-line screening 
appears to merit attention. So, too, does the possibility of using 
Cricetomys for first-line screening in under-served areas with high 
TB prevalence. Finally, further research is clearly needed to 
ascertain the rats' ability to detect TB in HIV-positive patients and in 
children, which were not treated as independent groups in the 
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